Olympus exercises option to acquire Medi-Tate

Olympus Corporation announced it has exercised its call option to acquire the remainder of shares in Medi-Tate Ltd., an Israeli medical device company specializing in minimally invasive treatment for benign prostatic hyperplasia. The acquisition aims to expand Olympus' urology business.

“the investment in Medi-Tate has expanded our patient care offerings in BPH, adding to Olympus’ market-leading plasma resection portfolio for transurethral resection of the prostate (TURP).”olympusamerica.com

• 2 sources
• olympusamerica.comOlympus Exercises Option to Buy Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth | OlympusFeb 26, 2021
• mpo-mag.comOlympus to Purchase Israeli Firm Medi-Tate to Grow Urology Biz | Medical Product OutsourcingSam BruscoMar 2, 2021

Summarized from public sources; check the original articles before acting on it.